SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation

Immunocompromised patients, including HSCT recipients, may have a poor prognosis after contracting COVID-19 due to the absence of a pathogen-specific adaptive immune response. One of the possible options for severe COVID-19 treatment may be the transfusion of hyperimmune SARS-CoV-2 convalescent plas...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transfus Apher Sci
Asıl Yazarlar: Balashov, Dmitry, Trakhtman, Pavel, Livshits, Anna, Kovalenko, Irina, Tereshenko, Galina, Solopova, Galina, Petraikina, Elena, Maschan, Alexei, Novichkova, Galina
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elsevier Ltd. 2021
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7604030/
https://ncbi.nlm.nih.gov/pubmed/33153902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.transci.2020.102983
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller